-+ 0.00%
-+ 0.00%
-+ 0.00%

NEWCELX UPDATES CORPORATE PRESENTATION TO HIGHLIGHT TYPE 1 DIABETES FLAGSHIP PROGRAM FOLLOWING STRATEGIC COLLABORATION WITH ELEDON PHARMACEUTICALS AHEAD OF SWISS BIOTECH CONFERENCE

Reuters·04/20/2026 11:37:00

Please log in to view news